QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, June 20, 2007, 27(25):6823-6831; doi:10.1523/JNEUROSCI.0013-07.2007

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Mark, K. A. Articles by Yamamoto, B. K. Search for Related Content PubMed PubMed Citation Articles by Mark, K. A. Articles by Yamamoto, B. K.

 Previous Article  |  Next Article 

Neurobiology of Disease
Dynamic Changes in Vesicular Glutamate Transporter 1 Function and Expression Related to Methamphetamine-Induced Glutamate Release

Karla A. Mark,¹ Maria S. Quinton,¹ Shelley J. Russek,² and Bryan K. Yamamoto¹

Laboratories of ¹Neurochemistry and ²Molecular Neurobiology, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118

Correspondence should be addressed to Bryan K. Yamamoto, Department of Pharmacology, Boston University School of Medicine, 715 Albany Street, L-613, Boston, MA 02118. Email: bkyam{at}bu.edu

The vesicular glutamate (GLU) transporter (VGLUT1) is a critical component of glutamatergic neurons that regulates GLU release. Despite the likely role of GLU release in drug abuse pathology, there is no information that links VGLUT1 with drugs of abuse. This study provides the first evidence that methamphetamine (METH) alters the dynamic regulation of striatal VGLUT1 function and expression through a polysynaptic pathway. METH increases cortical VGLUT1 mRNA, striatal VGLUT1 protein in subcellular fractions, and the V_max of striatal vesicular GLU uptake. METH also increases glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein in the crude vesicle fraction. METH-induced increases in cortical VGLUT1 mRNA, as well as striatal VGLUT1 and GAPDH, are GABA_A receptor-dependent because they are blocked by GABA_A receptor antagonism in the substantia nigra. These results show that VGLUT1 can be dynamically regulated via a polysynaptic pathway to facilitate vesicular accumulation of GLU for subsequent release after METH.

Key words: methamphetamine; VGLUT1; basal ganglia; striatum; substantia nigra; glutamate

---

Received Jan. 3, 2007; revised April 18, 2007; accepted May 11, 2007.

Correspondence should be addressed to Bryan K. Yamamoto, Department of Pharmacology, Boston University School of Medicine, 715 Albany Street, L-613, Boston, MA 02118. Email: bkyam{at}bu.edu

This article has been cited by other articles:

				H. Nakajima, W. Amano, T. Kubo, A. Fukuhara, H. Ihara, Y.-T. Azuma, H. Tajima, T. Inui, A. Sawa, and T. Takeuchi Glyceraldehyde-3-phosphate Dehydrogenase Aggregate Formation Participates in Oxidative Stress-induced Cell Death J. Biol. Chem., December 4, 2009; 284(49): 34331 - 34341. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help